STIM Neuronetics, Inc.
2.170USD-1.81%Mkt Cap: 165.35M $P/E: —1d ago
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap165.35M USD
Enterprise Value239.51M USD
Revenue (TTM)155.10M USD
Gross Profit72.31M USD
Net Income (TTM)-39.00M USD
Revenue/Share2.23 USD
Last Price2.170 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees658
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.50
PEG—
EV/EBITDA-12.43
EV/Revenue1.54
P/S1.09
P/B9.44
EPS (TTM)-0.43
EPS (Forward)-0.34
52W Range
0.800052% of range3.440
52W High3.440 USD
52W Low0.8000 USD
Profitability
Gross Margin48.48%
Oper. Margin-3.61%
EBITDA Margin-12.42%
Profit Margin-26.15%
ROE-174.27%
ROA-27.55%
Growth
Revenue Growth9.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.37M USD
CapEx (TTM)801.00K USD
FCF Margin0.22%
FCF Yield0.21%
Net Debt67.33M USD
Net Debt/EBITDA-3.50
Balance Sheet
Debt/Equity4.04
Current Ratio1.88
Quick Ratio1.25
Book Value/Sh0.23 USD
Cash/Share0.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.750 USD
Upside (mean)+165.0%
Target Range5.000 USD – 7.000 USD
5.000+165.0% to mean7.000
# Analysts4
Ownership
Shares Out.76.20M
Float37.15M
Insiders30.88%
Institutions54.00%
Short Interest
Short Ratio4.7d
Short % Float15.16%
Short % Out.8.15%
Shares Short6.21M
Short (prev mo.)8.05M
Technical
SMA 502.693 (-19.4%)
SMA 2001.825 (+18.9%)
Beta1.20
S&P 52W Chg16.45%
Avg Vol (30d)1.21M
Avg Vol (10d)888.80K
Technical Indicators
RSI (14)33.6
MACD-0.1303
MACD Signal-0.0413
MACD Hist.-0.0890
BB Upper3.319 USD
BB Middle2.653 USD
BB Lower1.987 USD
BB Width50.19%
ATR (14)0.1800 USD
Vol Ratio (20d)0.50x